Oracle Diagnostics Inc. said it has entered into a five-yearmanufacturing agreement under which DiagnosticBiotechnology Ltd. of Singapore will produce OraScreen HIVRapid Test Kits for Oracle.
The kits test for presence of HIV-1 antibodies in saliva. Thecompany said it is targeting niche markets not covered byblood-based HIV tests.
The Foster City, Calif., company, founded last October, licensedexclusive rights to the "dipstick" saliva-based technology fromthe University of Florida, Gainesville.
(c) 1997 American Health Consultants. All rights reserved.